Maintenance and Intensification of Bivalent Oral Poliovirus Vaccine Use Prior to its Coordinated Global Cessation | Zendy

Radboud J. Duintjer Tebbens | Zendy; Lee M. Hampton | Zendy; Steven G.F. Wassilak | Zendy; Mark A. Pallansch | Zendy; Stephen L. Cochi | Zendy; Kimberly M. Thompson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Maintenance and Intensification of Bivalent Oral Poliovirus Vaccine Use Prior to its Coordinated Global Cessation

Author(s) -

Radboud J. Duintjer Tebbens,

Lee M. Hampton,

Steven G.F. Wassilak,

Mark A. Pallansch,

Stephen L. Cochi,

Kimberly M. Thompson

Publication year - 2016

Publication title -

journal of vaccines and vaccination

Language(s) - English

Resource type - Journals

ISSN - 2157-7560

DOI - 10.4172/2157-7560.1000340

Subject(s) - poliovirus , medicine , population , inactivated poliovirus vaccine , poliomyelitis , herd immunity , serotype , immunity , outbreak , transmission (telecommunications) , virology , poliomyelitis eradication , environmental health , immunology , virus , immune system , electrical engineering , engineering

To examine the impact of different bivalent oral poliovirus vaccine (bOPV) supplemental immunization activity (SIA) strategies on population immunity to serotype 1 and 3 poliovirus transmission and circulating vaccine-derived poliovirus (cVDPV) risks before and after globally-coordinated cessation of serotype 1 and 3 oral poliovirus vaccine (OPV13 cessation).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research